Vnitr Lek 2012, 58(3):177-178

Gen pro FTO a jeho role v genetické determinaci obezity - editorial

L. Dušátková*, V. Hainer
Endokrinologický ústav Praha, ředitelka RNDr. Běla Bendlová, CSc.

Received: September 14, 2011; Published: March 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dušátková L, Hainer V. Gen pro FTO a jeho role v genetické determinaci obezity - editorial. Vnitr Lek. 2012;58(3):177-178.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Frayling TM, Timpson NJ, Weedon MN et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007; 316: 889-894. Go to original source... Go to PubMed...
    2. Hinney A, Vogel CI, Hebebrand J. From monogenic to polygenic obesity: recent advances. Eur Child Adolesc Psychiatry 2010; 19: 297-310. Go to original source... Go to PubMed...
    3. Ho AJ, Stein JL, Hua X et al. Alzheimer's Disease Neuroimaging Initiative. A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. Proc Natl Acad Sci USA 2010; 107: 8404-8409. Go to original source... Go to PubMed...
    4. Scuteri A, Sanna S, Chen WM et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet 2007; 3: e115. Go to original source... Go to PubMed...
    5. Taki Y, Kinomura S, Sato K et al. Relationship between body mass index and gray matter volume in 1,428 healthy individuals. Obesity (Silver Spring) 2008; 16: 119-124. Go to original source... Go to PubMed...
    6. Raji CA, Ho AJ, Parikshak NN et al. Brain structure and obesity. Hum Brain Mapp 2010; 31: 353-364. Go to original source... Go to PubMed...
    7. Matějovská Kubešová H, Meluzínová H, Weber P. Faktory ovlivňující vznik a průběh kongnitivních poruch u seniorů. Vnitř Lék 2011; 57: 502-506. Go to PubMed...
    8. Luchsinger JA, Cheng D, Tang MX et al. Central Obesity in the Elderly is Related to Late-onset Alzheimer Disease. Alzheimer Dis Assoc Disord 2011 Jun 9.
    9. Keller L, Xu W, Wang HX et al. The obesity related gene, FTO, interacts with APOE, and is associated with Alzheimer's disease risk: a prospective cohort study. J Alzheimers Dis 2011; 23: 461-469. Go to original source... Go to PubMed...
    10. Kivimäki M, Jokela M, Hamer M et al. Examining overweight and obesity as risk factors for common mental disorders using fat mass and obesity-associated (FTO) genotype-instrumented analysis: The Whitehall II Study, 1985-2004. Am J Epidemiol 2011; 173: 421-429. Go to original source... Go to PubMed...
    11. Benedict C, Jacobsson JA, Rönnemaa E et al. The fat mass and obesity gene is linked to reduced verbal fluency in overweight and obese elderly men. Neurobiol Aging 2011; 32: 1159.e1-e5. Go to original source... Go to PubMed...
    12. Lim LS, Tai ES, Aung T et al. Relation of age-related cataract with obesity and obesity genes in an Asian population. Am J Epidemiol 2009; 169: 1267-1274. Go to original source... Go to PubMed...
    13. Doney AS, Dannfald J, Kimber CH et al. The FTO gene is associated with an atherogenic lipid profile and myocardial infarction in patients with type 2 diabetes: a Genetics of Diabetes Audit and Research Study in Tayside Scotland (Go-DARTS) study. Circ Cardiovasc Genet 2009; 2: 255-259. Go to original source... Go to PubMed...
    14. Dusatkova L, Zamrazilova H, Sedlackova B et al. Association of the FTO variant rs9939609 with metabolic syndrome in overweight/obese and representative cohorts of Czech adolescents. Int J Obes 2011; 35 (Suppl 1): S11.
    15. Pausova Z, Syme C, Abrahamowicz M et al. A common variant of the FTO gene is associated with not only increased adiposity but also elevated blood pressure in French Canadians. Circ Cardiovasc Genet 2009; 2: 260-269. Go to original source... Go to PubMed...
    16. Gerken T, Girard CA, Tung YC et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 2007; 318: 1469-1472. Go to original source... Go to PubMed...
    17. Mangge H, Renner W, Almer G et al. Rs9939609 variant of the fat mass and obesity-associated gene and trunk obesity in adolescents. J Obes 2011; 2011: 186368. Go to original source... Go to PubMed...
    18. Cauchi S, Stutzmann F, Cavalcanti-Proença C et al. Combined effects of MC4R and FTO common genetic variants on obesity in European general populations. J Mol Med (Berl) 2009; 87: 537-546. Go to original source... Go to PubMed...
    19. Greenfield JR, Miller JW, Keogh JM et al. Modulation of blood pressure by central melanocortinergic pathways. N Engl J Med 2009; 360: 44-52. Go to original source... Go to PubMed...
    20. Hardy R, Wills AK, Wong A et al. Life course variations in the associations between FTO and MC4R gene variants and body size. Hum Mol Genet 2010; 19: 545-552. Go to original source... Go to PubMed...
    21. Ahmad T, Chasman DI, Mora S et al. The fatmass and obesity-associated (FTO) gene, physical activity, and risk of incident cardiovascular events in white women. Am Heart J 2010; 160: 1163-1169. Go to original source... Go to PubMed...
    22. Razquin C, Marti A, Martinez JA. Evidences on three relevant obesogenes: MC4R, FTO and PPARγ. Approaches for personalized nutrition. Mol Nutr Food Res 2011; 55: 136-149. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.